Merck Drops ITC Probe Into Patented Folate Supplements

Law360, New York (June 11, 2013, 7:25 PM EDT) -- A subsidiary of Swiss Merck KgaA and others have asked the U.S. International Trade Commission to drop its probe into allegations that smaller rivals were importing generic folate supplements that contained patent-protected ingredients, according to papers filed Monday.

Merck & Cie, Pamlab LLC — now a Nestle S.A. subsidiary — and South Alabama Medical Science Foundation asked the trade body to halt its investigation into Gnosis SpA, Macoven Pharmaceuticals Inc. and Viva Pharmaceutical Inc. while the agency considers joint motions to terminate the probe.

Merck and...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.